Bone marrow-derived mesenchymal stem cells attenuate pulmonary inflammation and lung damage caused by highly pathogenic avian influenza A/H5N1 virus in BALB/c mice

• Main Authors: Resti Yudhawati Meliana, -, Muhammad Amin, -, Fedik A. Rantam, -, Rima R. Prasetya, -, Jezzy R. Dewantari, -, Aldise M. Nastri, -, Emmanuel D. Poetranto, -, Laksmi Wulandari, -, Maria Inge Lusida, -, Soetjipto Koesnowidagdo, -, Gatot Soegiarto, -, Yohko K. Shimizu, -, Yasuko Mori, -, Kazufumi Shimizu, -
• Format: Article PeerReviewed
• Language: English; English; English; English
• Published: BioMed Central Ltd. 2020
• Subjects: R Medicine (General); RC Internal medicine
• Online Access: https://repository.unair.ac.id/118326/1/1.%20Kualitas%20Karil_Artikel%2016.pdf; https://repository.unair.ac.id/118326/2/3.%20TURNITIN_Artikel%2016.pdf; https://repository.unair.ac.id/118326/3/2.%20Full%20Text_Artikel%2016.pdf; https://repository.unair.ac.id/118326/7/1.Karil_13.pdf; https://repository.unair.ac.id/118326/; https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05525-2; https://doi.org/10.1186/s12879-020-05525-2
• Institution: Universitas Airlangga

Background The highly pathogenic avian influenza A/H5N1 virus is one of the causative agents of acute lung injury (ALI) with high mortality rate. Studies on therapeutic administration of bone marrow-derived mesenchymal stem cells (MSCs) in ALI caused by the viral infection have been limited in numbe...